Cargando…
Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/ https://www.ncbi.nlm.nih.gov/pubmed/33584318 http://dx.doi.org/10.3389/fphar.2021.609508 |
| _version_ | 1783650326683844608 |
|---|---|
| author | Vorobjeva, Nina V. Sud'ina, Galina F. Chernyak, Boris V. |
| author_facet | Vorobjeva, Nina V. Sud'ina, Galina F. Chernyak, Boris V. |
| author_sort | Vorobjeva, Nina V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7878366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78783662021-02-13 Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 Vorobjeva, Nina V. Sud'ina, Galina F. Chernyak, Boris V. Front Pharmacol Pharmacology Frontiers Media S.A. 2021-01-29 /pmc/articles/PMC7878366/ /pubmed/33584318 http://dx.doi.org/10.3389/fphar.2021.609508 Text en Copyright © 2021 Vorobjeva, Sud'ina and Chernyak. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Vorobjeva, Nina V. Sud'ina, Galina F. Chernyak, Boris V. Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title | Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title_full | Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title_fullStr | Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title_full_unstemmed | Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title_short | Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| title_sort | mitochondria are potential targets for the development of new drugs against neutrophilic inflammation in severe pneumonia including covid-19 |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/ https://www.ncbi.nlm.nih.gov/pubmed/33584318 http://dx.doi.org/10.3389/fphar.2021.609508 |
| work_keys_str_mv | AT vorobjevaninav mitochondriaarepotentialtargetsforthedevelopmentofnewdrugsagainstneutrophilicinflammationinseverepneumoniaincludingcovid19 AT sudinagalinaf mitochondriaarepotentialtargetsforthedevelopmentofnewdrugsagainstneutrophilicinflammationinseverepneumoniaincludingcovid19 AT chernyakborisv mitochondriaarepotentialtargetsforthedevelopmentofnewdrugsagainstneutrophilicinflammationinseverepneumoniaincludingcovid19 |